To see all protocols that comply with the WHO Essential Medicine List 

This resource provides guidance on how to safely undertake the procedure. Institutional practice may vary in accordance with local policy.

Only health care professionals who have attained competency (as per institutional guidelines) should perform this procedure.

This document provides information on the safe administration of intravenous anti-cancer drugs via an intravenous cannula (IVC). Only health care professionals who have attained competency as per institutional guidelines in safe administration, handling and waste management of hazardous drugs should perform this procedure.

This procedure should be read in conjunction with the Safe handling of hazardous drugs document and the Safe administration of anti-cancer drugs document.

Note: Vesicant drugs should always be administered first. Ensure vein is patent and monitor for signs of extravasation throughout vesicant administration.

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information source. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

05 Feb 2023